As promised, there was more to come!

In this newsletter we have information and links to a Psilocybin Study in Aotearoa and to a newly released article including us by Feilidh Dwyer at the NZ Drug Foundation!

An Arden University student in New Zealand is completing a masters is conducting a research study you should look into if you currently or have micro or macro-dosed in the past.

A note from Natalie:

'Kia ora, my name is Natalie, and I am a kiwi who is doing research for the completion of a MSc Psychology through Arden University in the UK. I am interested in the knowledge that those who have past/historical experience of self-medicating with psilocybin for any type of mental distress under the umbrella term of depression have through personal experience.

I am currently looking for participants for a study investigating changes in subjective wellbeing and quality of life for those self-medicating with psilocybin in an Aotearoa New Zealand community sample. Participants need to have a past/historical experience of self-medicating with psilocybin for any type of mental distress under the umbrella term of depression. 

As many of you will be aware, there is a growing amount of research being conducted in the scientific community that there may be a relationship between psilocybin use and symptoms associated with depression. This study is open to New Zealand residents over the age of 18. The study should take approximately 15-20m to complete. 

Your contribution to this research is greatly appreciated and will provide information that is intended to help in the understanding of an underground movement that has arisen from a necessity for alternative solutions to symptoms of depression.

Data collected will contribute to the limited amount of information on self-medicating with psilocybin for depression within the community in Aotearoa.

All participants will remain anonymous. 

Happy to answer any questions '

These types of studies are crucial steps forward in progressing towards clinical trials. Please get involved!

Click button below to go to the experiment or if you have any questions, contact Natalie at natalieesmith7@gmail.com

Additionally, we are so excited to share with you a beautiful and long awaited article by Feilidh Dwyer at the NZ Drug Foundation which has just been released on their website and to us!

A Psychedelic Renaissance? 'Blue Honey' and what's next for psilocybin in Aotearoa: Inspired by their own experiences with psilocybin's "healing and transformative effects," Zach and Michaela wrote the book to share knowledge, provide a non-judgmental space for similar stories, and challenge negative perceptions of psilocybin as dangerous. They use the abbreviation 'MCP,' short for mushrooms containing psilocybin, to counter what they see as stigmatising associations with terms like 'magic mushrooms.'